Compounds > colistimethate sodium
Page last updated: 2024-09-05

colistimethate sodium and Kidney Diseases

colistimethate sodium has been researched along with Kidney Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jeong, ES; Jeong, J; Kim, DH; Kim, G; Kim, HS; Kim, YB; Moon, KS; Oh, JH; Shin, JG1
Alvarez-Lerma, F; Benito, N; Campillo, N; Esteve, E; Grau, S; Herrera, S; Horcajada, JP; Luque, S; Montero, M; Segura, C; Sorlí, L1
Brienza, N; Bruno, F; Coppolecchia, S; Dalfino, L; Miragliotta, G; Monno, R; Mosca, A; Puntillo, F; Spada, ML1

Other Studies

3 other study(ies) available for colistimethate sodium and Kidney Diseases

ArticleYear
Characterization of urinary metabolites as biomarkers of colistin-induced nephrotoxicity in rats by a liquid chromatography/mass spectrometry-based metabolomics approach.
    Toxicology letters, 2016, Apr-25, Volume: 248

    Topics: Amino Acids; Animals; Anti-Bacterial Agents; Biomarkers; Chromatography, High Pressure Liquid; Colistin; Creatinine; Kidney Diseases; Male; Metabolomics; Multivariate Analysis; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tissue Distribution

2016
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
    BMC infectious diseases, 2017, 01-05, Volume: 17, Issue:1

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Availability; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Kidney Diseases; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome; Young Adult

2017
High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Colistin; Critical Illness; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Sepsis; Treatment Outcome

2012